3540 — CI Medical Co Income Statement
0.000.00%
- ¥42bn
- ¥60bn
- ¥67bn
- 51
- 60
- 42
- 52
Annual income statement for CI Medical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37,394 | 41,205 | 42,891 | 45,628 | 67,493 |
Cost of Revenue | |||||
Gross Profit | 11,294 | 11,605 | 11,673 | 11,995 | 21,288 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32,924 | 36,977 | 39,084 | 42,526 | 60,504 |
Operating Profit | 4,470 | 4,228 | 3,807 | 3,102 | 6,989 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,451 | 4,285 | 3,851 | 3,184 | 7,078 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,921 | 2,821 | 2,525 | 2,100 | 6,301 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,921 | 2,821 | 2,522 | 2,084 | 6,267 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,921 | 2,820 | 2,521 | 2,082 | 6,266 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 61.5 | 60.3 | 53.2 | 41.6 | 46.5 |
Dividends per Share | |||||
Special Dividends per Share |